FTFinancial Times·1hBusiness
score+0.20
Ozempic-maker Novo open to upgrading US listing
Original
Ozempic-maker Novo open to upgrading US listing
“Standard corporate business news reporting with mild positive valence due to the CEO's stated view on advantages, lacking strong emotional triggers.”